









Markets
/
Stocks
/
nasdaq-zntl
/

Zentalis Pharmaceuticals Inc

ZNTL

1.407USD

+0.067+5.03%

Market hours （ET）Quotes delayed by 15 min

101.26MMarket Cap

LossP/E TTM



Zentalis Pharmaceuticals Inc

1.407

+0.067+5.03%

Overview Company Financials

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q1

Total revenue

-100.00%0.00

--26.86M

--0.00

--40.56M

----

Revenue

--0.00

--26.86M

--0.00

----

Operating expenses

-43.86%36.67M

7.44%72.98M

-17.99%51.43M

11.65%65.15M

8.96%65.33M

31.24%67.92M

15.73%62.72M

-8.06%58.35M

3.58%59.95M

7.39%51.75M

0.23%54.19M

15.11%63.46M

14.96%57.88M

19.75%48.19M

55.52%54.07M

101.39%55.13M

207.01%50.35M

--40.24M

--34.77M

--27.38M

88.02%16.40M

--8.72M

R&D expenses

-47.37%26.09M

-36.05%32.97M

-21.26%36.82M

13.36%48.39M

2.06%49.59M

26.94%51.56M

10.87%46.77M

-2.60%42.68M

5.36%48.58M

5.66%40.62M

-6.68%42.18M

-2.11%43.83M

20.10%46.11M

30.21%38.44M

83.21%45.20M

156.53%44.77M

189.59%38.39M

--29.52M

--24.67M

--17.45M

87.02%13.26M

--7.09M

Depreciation, depletion, and amortization

-19.14%262.00K

-5.75%328.00K

0.00%348.00K

-4.94%327.00K

-10.00%324.00K

-3.06%348.00K

-7.20%348.00K

-1.15%344.00K

4.65%360.00K

71.77%359.00K

173.72%375.00K

192.44%348.00K

335.44%344.00K

186.30%209.00K

168.63%137.00K

213.16%119.00K

107.89%79.00K

--73.00K

--51.00K

--38.00K

80.95%38.00K

--21.00K

Operating profit

-48.09%-36.67M

32.11%-46.11M

17.99%-51.43M

-11.65%-65.15M

58.69%-24.77M

-31.24%-67.92M

-15.73%-62.72M

8.06%-58.35M

-3.58%-59.95M

-7.39%-51.75M

-0.23%-54.19M

-15.11%-63.46M

-14.96%-57.88M

-19.75%-48.19M

-55.52%-54.07M

-101.39%-55.13M

-207.01%-50.35M

---40.24M

---34.77M

---27.38M

-88.02%-16.40M

---8.72M

Net non-operating interest income (expenses)

Non-operating interest income

----

-12.80%143.00K

----

121.62%164.00K

--74.00K

Gains from sale of securities

-107.60%-2.66M

-68.28%2.17M

56.01%11.25M

-613.66%-22.86M

750.52%34.95M

111.88%6.85M

278.43%7.21M

949.76%4.45M

864.55%4.11M

3572.73%3.23M

1824.24%1.91M

268.70%424.00K

--426.00K

-72.06%88.00K

-17.50%99.00K

36.90%115.00K

----

--315.00K

--120.00K

--84.00K

----

Special income (expenses)

---8.95M

---3.74M

--0.00

100.00%0.00

----

--0.00

---45.57M

---5.00M

--0.00

-100.00%0.00

----

--0.00

--42.78M

----

Other non-operating income (expenses)

----

---44.00K

----

100.00%0.00

---12.00K

Income before tax

-574.11%-48.28M

21.94%-47.68M

27.61%-40.19M

11.52%-88.01M

116.74%10.18M

-25.87%-61.07M

-6.16%-55.51M

-57.79%-99.47M

-5.90%-60.84M

-0.87%-48.52M

-367.32%-52.29M

-14.58%-63.04M

-14.34%-57.45M

-20.47%-48.10M

67.71%-11.19M

-101.59%-55.02M

-209.50%-50.25M

---39.93M

---34.65M

---27.29M

-87.47%-16.23M

---8.66M

Income tax

-100.00%0.00

-51.85%-205.00K

-187.10%-27.00K

143.97%266.00K

32.41%143.00K

62.50%-135.00K

119.50%31.00K

-3658.82%-605.00K

227.27%108.00K

-326.42%-360.00K

77.19%-159.00K

-62.22%17.00K

-83.16%33.00K

-62.68%159.00K

-3972.22%-697.00K

--45.00K

--196.00K

--426.00K

--18.00K

----

--3.00K

Equity earnings after tax

----

--0.00

100.00%0.00

-156.73%-13.70M

-31.92%-2.31M

-272.58%-6.82M

---2.37M

---5.34M

---1.75M

---1.83M

----

Income after tax

-580.87%-48.28M

22.10%-47.47M

27.70%-40.16M

10.71%-88.28M

116.47%10.04M

-26.53%-60.94M

-6.54%-55.54M

-56.79%-98.86M

-6.03%-60.95M

0.21%-48.16M

-396.85%-52.13M

-14.51%-63.05M

-13.96%-57.49M

-19.60%-48.26M

69.73%-10.49M

-101.75%-55.06M

-210.71%-50.44M

---40.36M

---34.66M

---27.29M

-87.41%-16.23M

---8.66M

Net income from continuous operations

-580.87%-48.28M

22.10%-47.47M

27.70%-40.16M

21.58%-88.28M

115.87%10.04M

-10.83%-60.94M

-1.91%-55.54M

-64.59%-112.56M

-6.79%-63.26M

-9.76%-54.98M

-419.44%-54.50M

-24.21%-68.39M

-17.43%-59.24M

-24.13%-50.09M

69.73%-10.49M

-101.75%-55.06M

-210.71%-50.44M

---40.36M

---34.66M

---27.29M

-87.41%-16.23M

---8.66M

Net Income attributable to non-controlling interests

100.00%0.00

34.88%-28.00K

-69.23%-22.00K

87.88%-12.00K

-5.71%-37.00K

73.13%-43.00K

63.89%-13.00K

98.43%-99.00K

92.83%-35.00K

70.53%-160.00K

32.08%-36.00K

-5628.18%-6.30M

-12.18%-488.00K

-398.17%-543.00K

---53.00K

---110.00K

---435.00K

65.94%-109.00K

---320.00K

Net income attributable to controlling interests

-579.53%-48.28M

22.07%-47.47M

27.68%-40.16M

21.55%-88.28M

115.93%10.07M

-10.82%-60.92M

-2.07%-55.53M

-64.62%-112.53M

-7.01%-63.22M

-9.81%-54.97M

-1198.04%-54.40M

-25.26%-68.36M

-18.39%-59.08M

-24.21%-50.06M

87.87%-4.19M

-103.20%-54.57M

-209.44%-49.90M

---40.30M

---34.55M

---26.86M

-93.29%-16.13M

---8.34M

Net income attributable to common shareholders

-579.53%-48.28M

22.07%-47.47M

27.68%-40.16M

21.55%-88.28M

115.93%10.07M

-10.82%-60.92M

-2.07%-55.53M

-64.62%-112.53M

-7.01%-63.22M

-9.81%-54.97M

-1198.04%-54.40M

-25.26%-68.36M

-18.39%-59.08M

-24.21%-50.06M

87.87%-4.19M

-103.20%-54.57M

-209.44%-49.90M

---40.30M

---34.55M

---26.86M

-93.29%-16.13M

---8.34M

Basic earnings per share

-574.30%-0.67

22.55%-0.67

28.19%-0.56

32.87%-1.24

113.32%0.14

9.05%-0.86

17.88%-0.79

-38.42%-1.85

18.32%-1.07

15.00%-0.95

-919.32%-0.96

0.18%-1.34

-5.61%-1.31

-10.47%-1.11

89.68%-0.09

-96.21%-1.34

-164.53%-1.24

---1.01

---0.91

---0.68

-93.28%-0.47

---0.24

Diluted earnings per share

-576.28%-0.67

22.55%-0.67

28.19%-0.56

32.87%-1.24

113.26%0.14

9.05%-0.86

17.88%-0.79

-38.42%-1.85

18.32%-1.07

15.00%-0.95

-919.32%-0.96

0.18%-1.34

-5.61%-1.31

-10.47%-1.11

89.68%-0.09

-96.21%-1.34

-164.53%-1.24

---1.01

---0.91

---0.68

-93.28%-0.47

---0.24

Dividend per share

--0.00

Currency unit

USD

Audit opinions

KeyAI

